KAISA HEALTH (00876) Sets 25 Mar 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal

Bulletin Express

Mar 13

KAISA HEALTH Group Holdings Limited has scheduled a board meeting for Wednesday, 25 March 2026. According to the announcement, directors will review and approve the consolidated annual results for the financial year ended 31 December 2025 and consider a recommendation for a final dividend, if applicable.

The meeting was disclosed in a notice dated 13 March 2026 and signed by Chairman and Executive Director Kwok Ying Shing. The Board currently comprises six executive directors—Kwok Ying Shing, Luo Jun, Luo Tingting, Liu Lihao, Xie Binhong and Ye Haoda—alongside three independent non-executive directors, namely Dr. Liu Yanwen, Dr. Lyu Aiping and Li Zhiying.

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited have disclaimed responsibility for the contents of the announcement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/news/1199829388"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1199829388\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1199829388?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-13 22:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1199829388","market":"hk","top_or_hot":-1,"title":"KAISA HEALTH (00876) Sets 25 Mar 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal","media":"Bulletin Express","content":"<p>KAISA HEALTH Group Holdings Limited has scheduled a board meeting for Wednesday, 25 March 2026. According to the announcement, directors will review and approve the consolidated annual results for the financial year ended 31 December 2025 and consider a recommendation for a final dividend, if applicable.</p>\n<p>The meeting was disclosed in a notice dated 13 March 2026 and signed by Chairman and Executive Director Kwok Ying Shing. The Board currently comprises six executive directors—Kwok Ying Shing, Luo Jun, Luo Tingting, Liu Lihao, Xie Binhong and Ye Haoda—alongside three independent non-executive directors, namely Dr. Liu Yanwen, Dr. Lyu Aiping and Li Zhiying.</p>\n<p>Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited have disclaimed responsibility for the contents of the announcement.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>KAISA HEALTH (00876) Sets 25 Mar 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKAISA HEALTH (00876) Sets 25 Mar 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-13 22:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>KAISA HEALTH Group Holdings Limited has scheduled a board meeting for Wednesday, 25 March 2026. According to the announcement, directors will review and approve the consolidated annual results for the financial year ended 31 December 2025 and consider a recommendation for a final dividend, if applicable.</p>\n<p>The meeting was disclosed in a notice dated 13 March 2026 and signed by Chairman and Executive Director Kwok Ying Shing. The Board currently comprises six executive directors—Kwok Ying Shing, Luo Jun, Luo Tingting, Liu Lihao, Xie Binhong and Ye Haoda—alongside three independent non-executive directors, namely Dr. Liu Yanwen, Dr. Lyu Aiping and Li Zhiying.</p>\n<p>Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited have disclaimed responsibility for the contents of the announcement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00876","symbol_name":"佳兆业健康","start_time":0,"source_url":"","article_id":"1199829388","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1199829388","pubTimestamp":1773412988,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"KAISA HEALTH Group Holdings Limited has scheduled a board meeting for Wednesday, 25 March 2026. According to the announcement, directors will review and approve the consolidated annual results for...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00876":"佳兆业健康"},"translate_title":"佳兆业健康(00876)定于2026年3月25日召开董事会批准2025财年业绩及末期股息建议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00876":1},"content_text":"KAISA HEALTH Group Holdings Limited has scheduled a board meeting for Wednesday, 25 March 2026. According to the announcement, directors will review and approve the consolidated annual results for the financial year ended 31 December 2025 and consider a recommendation for a final dividend, if applicable.\nThe meeting was disclosed in a notice dated 13 March 2026 and signed by Chairman and Executive Director Kwok Ying Shing. The Board currently comprises six executive directors—Kwok Ying Shing, Luo Jun, Luo Tingting, Liu Lihao, Xie Binhong and Ye Haoda—alongside three independent non-executive directors, namely Dr. Liu Yanwen, Dr. Lyu Aiping and Li Zhiying.\nHong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited have disclaimed responsibility for the contents of the announcement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}